Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Mol Med (Berl). 2019 May 17;97(7):1033–1047. doi: 10.1007/s00109-019-01791-z

Table 1.

Assessment of intact heart function in AAV vs PBS-injected D166V HCM and WT-RLC mice.

Echocardiography
D166V AAV D166V PBS WT AAV WT PBS
No. of animals (n) 6F, 6M 5F, 3M 3F, 3M 3F, 3M
Heart/body (mg/g) 4.25±0.16 4.58±0.30 5.01±0.43 4.56±0.65
HR (bpm) 490±14 504±31 452±20 424±30
EF (%) 71±2 65±4 62±4 63±4
FS (%) 51±3 49±5 41±3 38±2
LVAW;d (mm) 1.06±0.04** 1.41±0.13 0.98±0.08 1.10±0.05
LVAW;s (mm) 1.78±0.09 2.04±0.16 1.57±0.09 1.65±0.05
LVID;d (mm) 3.64±0.14* 3.10±0.18 3.62±0.11 3.78±0.16
LVID;s (mm) 1.80±0.16 1.60±0.23 2.15±0.16 2.37±0.17
LVPW;d (mm) 0.96±0.04* 1.42±0.22 0.98±0.15 1.04±0.07
LVPW;s (mm) 1.60±0.09* 2.01±0.18 1.37±0.17 1.50±0.10
LV mass/corr (mg) 112.7±6.66 157.60±25.57 110.7±18.02 129.8±12.04
Doppler Analysis
IVCT (ms) 13.61±1.16* 19.22±2.05 15.14±1.10* 21.84±2.53
IVRT (ms) 20.82±1.25 19.59±2.62 15.90±1.54 15.66±1.25
MV A (mm/s) 533±44 447±54 345±39 318±29
MV E (mm/s) 810±44** 547±82 655±34 645±46
MV E/A 1.36±0.06 1.35±0.14 1.89±0.15 1.98±0.16
MPI 0.59±0.03* 0.69±0.03 0.66±0.05 0.80±0.06
Invasive Hemodynamics
SW (mmHg*μl) 2261±211*** 918±211 2892±151 2448±445
CO (μl min−1) 15686±1383*** 6653±1323 15243±1443 14006±2897
SV (μl) 31.27±2.48* 18.85±4.71 33.67±1.43 32.76±6.57
ESV (μl) 22.50±2.58 19.23±3.09 22.48±4.78 24.67±6.15
EDV (μl) 49.16±4.17* 35.70±3.59 53.80±3.25 53.92±11.02
Pes (mmHg) 86.08±2.98* 73.65±5.59 89.29±6.85 78.42±6.16
Ped (mmHg) 6.42±0.89 13.15±3.92 7.42±1.04 7.33±0.87
HR (bpm) 501±14 459±22 422±23 393±21
Ea (mmHg μl−1) 2.97±0.29* 5.34±1.00* 2.61±0.40 3.05±1.00
dP/dtmax (mmHg s−1) 8409±473 7441±998 6988±370 6426±663
−dP/dtmin (mmHg s−1) 5104±292 4961±729 7307±527 5825±595
Tau (ms) 9.93±0.66** 13.68±0.85* 7.89±0.37 7.77±0.59
ESPVR (mmHg μl−1) 2.56±0.45 2.42±0.48 2.29±0.41 2.74±0.34
EDPVR (mmHg μl−1) 0.13±0.03 0.29±0.09 0.16±0.06 0.11±0.02
PRSW (mmHg) 56.04±4.57* 36.36±5.85 55.15±5.77 58.50±3.92
dP/dtmax-EDV (mmHg s−1 μl−1) 110.7±11.75* 60.93±17.49 60.20±7.09* 113.5±16.00
Strain Analysis
COstr (μl min−1) 13344±1218*** 5250±543 12217±1583 13000±1192
EFstr (%) 79±3*** 56±4 62±5 62±2
FSstr (%) 49±4** 33±4 31±4 32±2
EDVstr (μl) 35.24±2.82* 24.10±3.02 48.13±8.14 46.68±3.74
SVstr (μl) 27.83±2.32** 13.93±2.65 29.10±4.07 29.07±2.45
GLS (%) −26.06±0.84**** −10.92±2.91 −20.63±2.05 −22.67±1.66

Data are mean ± SEM with *P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 depicting significance between AAV vs PBS treated mice, by Student’s t-test.

Abbreviations: Heart weight/body weight in mg/g; Heart weigh/tibia length in mg/mm; HR, heart rate in beats per minute; EF%, ejection fraction; FS%, fraction of shortening; LVAW, left ventricular anterior wall; LVID, left ventricular inner diameter; LVPW, left ventricular posterior wall; d, diastolic; s, systolic; IVRT, isovolumetric relaxation time; IVCT, isovolumetric contraction time; MV E/A, mitral valve inflow -peak E-wave to A-wave velocity ratio; E, transmitral early peak velocity; E’, early diastolic mitral annulus velocity; MPI, Myocardial Performance Index; CO, cardiac output; SW, stroke work; SV, stroke volume; ESV, end-systolic volume; EDV, end-diastolic volume; Pes, end-systolic pressure; Ped, end-diastolic pressure; Ea, arterial elastance; dP/dt max, peak rate for pressure rise; −dP/dtmin, peak rate for pressure decline; Tau, relaxation time constant; ESPVR, end-systolic PV relation (slope); EDPVR, end-diastolic PV relation (slope); PRSW, preload recruitable power stroke work; dP/dtmax-EDV, peak rate of rise in LV pressure-end diastolic volmne relationship; COstr, Cardiac Output-strain; EFstr, Ejection Fraction-strain; FSstr, Fractional Shortening-strain; EDVstr, End Diastolic Volume-strain; SVstr, Stroke Volume-strain; GLS, global longitudinal strain.